Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Radiation improves long-term advantage in breast cancer:

This article was originally published in Clinica

Executive Summary

Providing high-risk breast cancer patients with radiation therapy in addition to chemotherapy, may add significant benefit than just chemotherapy alone. So finds a 20-year study, published in Journal of the National Cancer Institute (January 19), which observed that patients who received radiation therapy and adjuvant chemotherapy, compared to chemotherapy alone, had significant improvements in breast cancer survival (48%, versus 30%) and overall survival (47%, versus 37%). All 318 pre-menopausal women enrolled on the study had previously been treated with modified radical mastectomy and lymph node removal.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054105

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel